All insights
EU MDR PMSPostmarket evidence cleanupSource review as of 2026-06-08

EU MDR PMS When the Notified Body Asks for the Evidence Thread

When a regulatory lead is preparing for a notified-body postmarket evidence conversation, the problem is that source checks, internal records, clinical questions, and owner decisions may not line up as one evidence thread. The useful output is a postmarket evidence map that keeps source facts, owner questions, and qualified-review boundaries visible.

The practical first output is a source-backed PMS evidence map: what EU MDR and guidance sources can show, what internal records exist, which owner controls each evidence gap, and which conclusions remain with qualified reviewers.

For one regulatory lead before a notified-body postmarket evidence conversation.

The scene

Picture the regulatory affairs manager in a notified-body prep call before the PMS plan and clinical evaluation report update are reviewed. The team has complaints, literature notes, PMCF questions, vigilance checks, and management-review slides, but the thread between them is hard to follow.

A useful PMS article does not declare the file acceptable. It helps the team prepare the evidence trail so the qualified RA/QA, clinical, and notified-body-facing reviewers can inspect the logic.

Source ledger workflow

  • EU MDR source text: which PMS, vigilance, clinical, or technical-documentation question it informs.
  • MDCG guidance: which preparation question it helps frame and where interpretation remains open.
  • Internal record: complaint trend, PMCF note, CER section, risk-file update, vigilance assessment, or management-review action.
  • Owner and next action: who validates the record, what is missing, and when it returns for qualified review.

Evidence-thread map

Thread elementQuestion to answer
TriggerWhy is the PMS file being reviewed now?
Public sourceWhich EU MDR or MDCG source frames the question?
Internal evidenceWhich record supports or challenges the current narrative?
GapWhat evidence, owner, or rationale is missing?
Decision boundaryWhich conclusions remain with qualified reviewers?

Source ledger

Regulation (EU) 2017/745 on medical devices

What it can tell you

EU MDR source text for postmarket surveillance, vigilance, clinical evaluation, and related manufacturer obligations.

What it cannot decide

Whether a specific PMS plan, PSUR, PMCF plan, clinical evaluation update, or technical file is acceptable.

European Commission medical devices sector

What it can tell you

European Commission medical-device sector context, including implementation resources and public guidance locations.

What it cannot decide

How a specific notified body will assess one manufacturer's PMS evidence thread.

MDCG endorsed guidance documents

What it can tell you

Public MDCG guidance references that may inform PMS, PMCF, clinical, vigilance, and technical-documentation preparation.

What it cannot decide

Which guidance interpretation controls a specific device, claim, classification, or conformity-assessment file.

Frequently asked questions

Can this determine whether a PMS plan will satisfy a notified body?

No. It organizes evidence and open questions. Acceptability, conformity-assessment, clinical, legal, and regulatory conclusions remain with qualified reviewers and the notified-body process.

What is the first useful output?

A PMS evidence-thread map with source links, internal record IDs, owner assignments, gaps, and next review questions.

Need an EU MDR PMS evidence thread before the review call?

Send the product family, PMS trigger, and open reviewer question. We can scope a source-backed evidence thread for qualified review.

Reader feedback

Useful pages should feed the next topic choices. Leave a signal or a short comment.

0 approved comments0 awaiting review
Comments are reviewed before they appear publicly. Keep it non-confidential and focused on what helped or what was still unclear.